Latest Breaking News On - Taiwan securities - Page 1 : vimarsana.com

Cheng Shin's revenue in 2023 decreased 2.08%

Cheng Shin Rubber has not yet disclosed its 2023 annual report, but it announced its 2023 revenue on the Taiwan Securities Exchange. Compared with the previous year, Cheng Shin Rubber’s yearly revenue decreased by 2.08 per cent.

TaiwanTaiwan securities exchangeCheng shin rubberTaiwan securities

OBI Pharma Inc.: OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992

OBI Pharma Inc.: OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

ChinaTaiwanTaipeiT ai peiAdagloxad simoleninWayne savilleKevin poulosHeidi wangPharma incDrug administrationFutures bureauBiosion incChief medical officerChief executive officerPrivate securities litigation reform actTaiwan securities

OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992

OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-992
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

TaiwanTaipeiT ai peiChinaKevin poulosWayne savilleHeidi wangAdagloxad simoleninBiosion incPharma incDrug administrationFutures bureauChief medical officerChief executive officerPrivate securities litigation reform actTaiwan securities

Form 424B2 BARCLAYS PLC

Form 424B2 BARCLAYS PLC
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesLondonCity ofUnited kingdomLuxembourgSingaporeCity of new yorkUkraineHong kongBrusselsBruxelles capitaleBelgiumState of new yorkCanadaTaiwan

OBI Pharma Announces Executive Leadership Management Change – Heidi Wang, Ph.D. Appointed as Chief Executive Officer

Dr. Wang appointed by the OBI Pharma Board of Directors as Chief Executive Officer to lead OBI Pharma with a vision and to bring innovative cancer therapies to patients globally. She brings a wealth. | June 2, 2023

ChinaTaiwanTaipeiT ai peiTaiwaneseHeidi wangKevin poulosAdagloxad simoleninBristol myers squibbFutures bureauBristol myers squibb companyPharma united states incInternational regulatory strategyPharma incFu jen university taipeiHead of global regulatory sciences oncology